Quest Resource Holding Strengthens Commitment to UK's Naval Nuclear Sector through Strategic Partnership

Strengthening Engineering Excellence: Quest Global's Commitment to the UK's Naval Nuclear Sector

Quest Global, the world’s largest independent pure-play engineering services company, marks a pivotal moment in its ongoing partnership with Babcock International as they enter the third year of collaboration. This partnership underscores Quest Global's dedication to the UK's Naval Nuclear Sector and its critical infrastructure programmes. By focusing on upskilling talent in essential areas such as Naval Architecture, Electrical Power Distribution, and Decommissioning, Quest Global aims to address the pressing needs of the industry while supporting national security goals. Rob Vatter, Executive President of Quest Global, articulates the shared ambition of both companies to deliver transformative engineering outcomes that align with the UK's strategic objectives.

Since the inception of their partnership in July 2023, Quest Global has established itself as a trusted supplier, enabling Babcock to concentrate on its core operations. This collaboration not only enhances the engineering value of projects but also fortifies the capabilities necessary for the UK’s nuclear ambitions. Mark Prince, Nuclear Engineering Director at Babcock, emphasizes the confidence in Quest Global's ability to provide essential engineering services that contribute significantly to national interests. The partnership’s evolution into a more ambitious phase reflects a steadfast commitment to operational delivery and strategic alignment, ensuring that both companies remain focused on enhancing the UK's engineering landscape.

As Quest Global continues to expand its role within the UK’s Naval Nuclear Sector, the collaboration with Babcock International highlights a shared vision for fostering local talent and engineering excellence. With over 25 years of experience and a workforce of more than 21,500 employees across 18 countries, Quest Global is well-positioned to address complex engineering challenges. This partnership not only reinforces the company's commitment to innovation and operational excellence but also promises to deliver enduring value in support of key national initiatives, ultimately contributing to a secure and resilient future for the UK.

In related developments, Quest Diagnostics has recently advanced its capabilities in the field of Alzheimer's disease diagnosis with the launch of two blood-based tests, AD-Detect®. These tests demonstrate high accuracy and aim to reduce the need for more invasive procedures. With ongoing collaborations that align with evolving clinical needs, Quest Diagnostics continues to push the boundaries of diagnostic innovation.

As both Quest Global and Quest Diagnostics make strides in their respective fields, their commitment to quality and excellence highlights the importance of innovation in enhancing national capabilities and improving patient outcomes.